Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4323778)

Published in J Am Heart Assoc on October 07, 2014

Authors

Junbeom Park1, Tae-Hoon Kim1, Jihei Sara Lee1, Jin Kyu Park1, Jae Sun Uhm1, Boyoung Joung1, Moon Hyoung Lee1, Hui-Nam Pak1

Author Affiliations

1: Yonsei University Health System, Seoul, Korea (J.P., T.H.K., J.S.L., J.K.P., J.S.U., B.J., M.H.L., H.N.P.).

Articles cited by this

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32

Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr (2009) 14.63

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm (2012) 8.03

HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm (2007) 7.20

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA (2009) 5.22

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA (2014) 3.86

Genome-wide association study of PR interval. Nat Genet (2010) 3.73

Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor". J Am Coll Cardiol (2009) 2.27

Low heart rates predict incident atrial fibrillation in healthy middle-aged men. Circ Arrhythm Electrophysiol (2013) 2.12

Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm (2006) 1.86

Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation. J Am Coll Cardiol (2012) 1.54

P wave indices: current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol (2009) 1.35

Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation (2003) 1.32

Consistency of complex fractionated atrial electrograms during atrial fibrillation. Heart Rhythm (2008) 1.17

High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors--a 28-30 years follow-up study. Eur J Cardiovasc Prev Rehabil (2010) 1.15

Comparison of voltage map-guided left atrial anterior wall ablation versus left lateral mitral isthmus ablation in patients with persistent atrial fibrillation. Heart Rhythm (2010) 1.14

Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation. Circ Res (2007) 1.02

Prevalence of interatrial block in a general hospital population. Am J Cardiol (2003) 1.02

P-wave duration and dispersion in obese subjects. Ann Noninvasive Electrocardiol (2008) 1.00

The effect of diabetes mellitus on the P-wave dispersion. Circ J (2007) 0.99

First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study. Eur Heart J (2011) 0.98

Effects of percutaneous mitral balloon valvuloplasty on P-wave dispersion in patients with mitral stenosis. Am J Cardiol (2002) 0.98

Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts. Circ Cardiovasc Genet (2012) 0.97

The relationship between endocardial voltage and regional volume in electroanatomical remodeled left atria in patients with atrial fibrillation: comparison of three-dimensional computed tomographic images and voltage mapping. J Cardiovasc Electrophysiol (2009) 0.96

Detection of hypertensive patients at risk for paroxysmal atrial fibrillation during sinus rhythm by computer-assisted P wave analysis. J Hypertens (1999) 0.95

Electrophysiologic characteristics of complex fractionated atrial electrograms in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.93

Increased p-wave duration and p-wave dispersion in patients with aortic stenosis. Ann Noninvasive Electrocardiol (2003) 0.92

P-wave duration and dispersion in patients with obstructive sleep apnea. Int J Cardiol (2008) 0.91

Long-term prognostic value of p-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baseline. Am J Cardiol (2007) 0.87

Prognostic significance of prolonged PR interval in the general population. Eur Heart J (2013) 0.86

Heterogeneous changes in electrophysiologic properties in the paroxysmal and chronically fibrillating human atrium. J Cardiovasc Electrophysiol (1999) 0.85

Effects of primary percutaneous coronary intervention on P wave dispersion. Ann Noninvasive Electrocardiol (2005) 0.85

P-wave dispersion for predicting maintenance of sinus rhythm after cardioversion of atrial fibrillation. Am J Cardiol (2004) 0.83

Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hypertyroidism. Exp Clin Endocrinol Diabetes (2007) 0.81